BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34249624)

  • 1. Hepatic fat quantification of magnetic resonance imaging whole-liver segmentation for assessing the severity of nonalcoholic fatty liver disease: comparison with a region of interest sampling method.
    Zhang QH; Zhao Y; Tian SF; Xie LH; Chen LH; Chen AL; Wang N; Song QW; Zhang HN; Xie LZ; Shen ZW; Liu AL
    Quant Imaging Med Surg; 2021 Jul; 11(7):2933-2942. PubMed ID: 34249624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease.
    Martí-Aguado D; Jiménez-Pastor A; Alberich-Bayarri Á; Rodríguez-Ortega A; Alfaro-Cervello C; Mestre-Alagarda C; Bauza M; Gallén-Peris A; Valero-Pérez E; Ballester MP; Gimeno-Torres M; Pérez-Girbés A; Benlloch S; Pérez-Rojas J; Puglia V; Ferrández A; Aguilera V; Escudero-García D; Serra MA; Martí-Bonmatí L
    Radiology; 2022 Feb; 302(2):345-354. PubMed ID: 34783592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of water-fat MRI and proton MRS in assessment of hepatic fat and the heterogeneous distribution of hepatic fat and iron in subjects with non-alcoholic fatty liver disease.
    Hui SCN; So HK; Chan DFY; Wong SKH; Yeung DKW; Ng EKW; Chu WCW
    Eur J Radiol; 2018 Oct; 107():7-13. PubMed ID: 30292275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of reader agreement, correlation with liver biopsy, and time-burden sampling strategies for liver proton density fat fraction measured using magnetic resonance imaging in patients with obesity: a secondary cross-sectional study.
    Cao D; Li M; Liu Y; Jin H; Yang D; Xu H; Lv H; Liu J; Zhang P; Zhang Z; Yang Z
    BMC Med Imaging; 2022 May; 22(1):92. PubMed ID: 35581577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three segments sampling strategy for the assessment of liver steatosis using magnetic resonance imaging proton density fat fraction.
    Kim A; Kim M; Lee CM; Kang BK; Jun DW
    Eur J Radiol; 2023 Feb; 159():110653. PubMed ID: 36563563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI-determined liver proton density fat fraction, with MRS validation: Comparison of regions of interest sampling methods in patients with type 2 diabetes.
    Vu KN; Gilbert G; Chalut M; Chagnon M; Chartrand G; Tang A
    J Magn Reson Imaging; 2016 May; 43(5):1090-9. PubMed ID: 26536609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of multi-echo Dixon sequence in quantification of hepatic steatosis in Chinese children and adolescents.
    Zhao YZ; Gan YG; Zhou JL; Liu JQ; Cao WG; Cheng SM; Bai DM; Wang MZ; Gao FQ; Zhou SM
    World J Gastroenterol; 2019 Mar; 25(12):1513-1523. PubMed ID: 30948914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic MR imaging using IDEAL-IQ sequence: Will Gd-EOB-DTPA interfere with reproductivity of fat fraction quantification?
    Tian Y; Liu PF; Li JY; Li YN; Sun P
    World J Clin Cases; 2023 Sep; 11(25):5887-5896. PubMed ID: 37727487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous quantification of hepatic MRI-PDFF and R2* in a rabbit model with nonalcoholic fatty liver disease.
    Wang X; Zhang X; Ma L; Li S
    Sci China Life Sci; 2018 Sep; 61(9):1107-1114. PubMed ID: 29934919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic fat quantification using the two-point Dixon method and fat color maps based on non-alcoholic fatty liver disease activity score.
    Hayashi T; Saitoh S; Takahashi J; Tsuji Y; Ikeda K; Kobayashi M; Kawamura Y; Fujii T; Inoue M; Miyati T; Kumada H
    Hepatol Res; 2017 Apr; 47(5):455-464. PubMed ID: 27351583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring liver fat fraction with complex-based chemical shift MRI: the effect of simplified sampling protocols on accuracy.
    Procter AJ; Sun JY; Malcolm PN; Toms AP
    BMC Med Imaging; 2019 Feb; 19(1):14. PubMed ID: 30736759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic steatosis modeling and MRI signal simulations for comparison of single- and dual-R2* models and estimation of fat fraction at 1.5T and 3T.
    Shrestha U; Esparza JP; Satapathy SK; Vanatta JM; Abramson ZR; Tipirneni-Sajja A
    Comput Biol Med; 2024 May; 174():108448. PubMed ID: 38626508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accurate and simple method for quantification of hepatic fat content using magnetic resonance imaging: a prospective study in biopsy-proven nonalcoholic fatty liver disease.
    Hatta T; Fujinaga Y; Kadoya M; Ueda H; Murayama H; Kurozumi M; Ueda K; Komatsu M; Nagaya T; Joshita S; Kodama R; Tanaka E; Uehara T; Sano K; Tanaka N
    J Gastroenterol; 2010 Dec; 45(12):1263-71. PubMed ID: 20625773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative Comparison of Liver Volume, Proton Density Fat Fraction, and Time Burden between Automatic Whole Liver Segmentation and Manual Sampling MRI Strategies for Diagnosing Metabolic Dysfunction-associated Steatotic Liver Disease in Obese Patients.
    Cao D; Yang Y; Li M; Liu Y; Yang D; Xu H; Lv H; Zhang Z; Zhang P; Jia X; Yang Z
    Curr Med Imaging; 2024 Mar; ():. PubMed ID: 38462830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free-breathing quantification of hepatic fat in healthy children and children with nonalcoholic fatty liver disease using a multi-echo 3-D stack-of-radial MRI technique.
    Armstrong T; Ly KV; Murthy S; Ghahremani S; Kim GHJ; Calkins KL; Wu HH
    Pediatr Radiol; 2018 Jul; 48(7):941-953. PubMed ID: 29728744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease by Using Quantitative US.
    Han A; Zhang YN; Boehringer AS; Montes V; Andre MP; Erdman JW; Loomba R; Valasek MA; Sirlin CB; O'Brien WD
    Radiology; 2020 Apr; 295(1):106-113. PubMed ID: 32013792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver fat quantification: where do we stand?
    Starekova J; Reeder SB
    Abdom Radiol (NY); 2020 Nov; 45(11):3386-3399. PubMed ID: 33025153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphological characterization of hepatic steatosis and Monte Carlo modeling of MRI signal for accurate quantification of fat fraction and relaxivity.
    Shrestha U; van der Merwe M; Kumar N; Jacobs E; Satapathy SK; Morin C; Tipirneni-Sajja A
    NMR Biomed; 2021 Jun; 34(6):e4489. PubMed ID: 33586261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early detection of liver steatosis by magnetic resonance imaging in rats infused with glucose and intralipid solutions and correlation to insulin levels.
    d'Assignies G; Fontés G; Kauffmann C; Latour M; Gaboury L; Boulanger Y; Van Beers BE; Soulez G; Poitout V; Tang A
    Metabolism; 2013 Dec; 62(12):1850-7. PubMed ID: 24035445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver fat quantification: Comparison of dual-echo and triple-echo chemical shift MRI to MR spectroscopy.
    Satkunasingham J; Besa C; Bane O; Shah A; de Oliveira A; Gilson WD; Kannengiesser S; Taouli B
    Eur J Radiol; 2015 Aug; 84(8):1452-1458. PubMed ID: 26047820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.